More stories

  • in

    Hedge fund winners and losers emerge in brutal tech-driven sell-off

    Visit cnbcevents.com/delivering-alpha to register for this year’s conference on September 28, 2022.

    The stock market is going through a period of uncertainty and volatility, but some sectors could benefit from that.
    Timothy A. Clary | AFP | Getty Images

    (Click here to subscribe to the Delivering Alpha newsletter.)
    A wide divergence of performance has formed in the hedge fund industry amid the stock rout on Wall Street this year.

    Tech-focused investors like Brad Gerstner and Tiger Global are getting crushed as growth stocks became the epicenter of the market carnage in the face of rising rates. Meanwhile, some value, macro and international oriented players are reaping sizable gains despite the market bloodbath.
    Macro funds were a standout winner in April with a 5% surge, extending its 2020 rally to 15.5% thanks to strong performance in commodity, fundamental discretionary and trend-following strategies, according to data from HFR. On the flip side, technology-heavy hedge funds were among the biggest losers last month with a near 5% loss overall, HFR data said.
    “If you owned growth stocks this year – like we did at Altimeter – you got your face ripped off,” Altimeter Capital’s CEO Gerstner said in a Twitter post Thursday. “As a hedge fund we expect to lose less than the indexes on the way down – this year we have lost more… Markets moved fast- we moved too slow.”
    Altimeter’s four biggest holdings — Snowflake, Meta, Microsoft and Uber — are all down from 20% to as much as 60% year to date. The technology sector, especially unprofitable firms and richly valued software names, have been hit the hardest as of late. The Nasdaq Composite slid more than 13% in April, dropping almost 30% from its all-time high.

    Arrows pointing outwards

    Chase Coleman’s growth-focused flagship fund at Tiger Global tumbled 15% last month, pushing its 2022 rout to 44% and wiping out nearly all of its gains since 2019, according to Bloomberg News. Its biggest holdings as of the end of 2021 included JD.com, Microsoft and Sea Ltd, which are all down double digits this year.

    Still, many players managed to dodge the brutal sell-off and overcome the extreme volatility on Wall Street.
    Citadel’s multistrategy flagship fund Wellington rallied 7.5% last month, bringing its year-to-date performance to 12.7%.
    New York-based activist and event-driven hedge fund manager Coast Capital is also beating the market this year as they looked for out-of-favor value names in Europe. Its Engaged fund is up 4% in April, advancing over 15% in 2022, according to a person familiar with the returns.
    “Some of these companies we buy have lower valuations and lower share prices than they did in March 2009,” said James Rasteh, CIO of Coast. “When we turn our companies around, there’s often an important improvement in the margins and profitability of the companies. We make money even in declining markets.”
    The overall hedge fund community dipped 0.9% in April, compared to the S&P 500’s near 9% loss for its worst month since March 2020, according to HFR. The S&P 500 is edging closer to bear market territory, down 18% from its record high, as the Federal Reserve’s aggressive tightening spurred recession worries. More

  • in

    Franklin Templeton CEO Jenny Johnson says active management pays off during extreme volatility

    Visit cnbcevents.com/delivering-alpha to register for this year’s conference on September 28, 2022.

    (Click here to subscribe to the Delivering Alpha newsletter.)
    With $1.5 trillion in assets, Franklin Templeton is among America’s top 10 asset managers, and growing. Over the last few years, the firm has acquired asset manager Legg Mason, custom index provider O’Shaughnessy Asset Management, and secondary private equity investor Lexington Partners, among others. President and CEO Jenny Johnson says it doesn’t end there. She’s focused on bolt-on acquisitions in technology and alternatives to fill product gaps in Franklin Templeton’s business. 

    Johnson sat down with CNBC’s Delivering Alpha newsletter in an exclusive interview where she also discussed the firm’s active management strategy and made the case for implementing blockchain technology. 
     (The below has been edited for length and clarity. See above for full video.)
    Leslie Picker: I want to kick things off on the macro front, because there are a lot of questions out there. With such an inflection point for inflation and for monetary policy for factor-based investing, volatility, what are you seeing within your vast, diverse portfolio right now?
    Jenny Johnson: It’s no question, it’s a difficult time. And I would say the good news is, in times of great volatility, active management pays off. And we’re really an active management – 1.5 trillion – really an active management. So, it’s times like these that you find value. I think the challenge is, there is a lot of mixed signals. You have the obvious headwinds of inflation. The 50 basis points Fed raise has been the highest in 20 years and we’re looking at a couple of more coming up. I think they indicated today that we’re probably [looking at] two more increases, maybe even three, and then take a pause. So, you’re going to have this great rise in rates, you have with the war in Ukraine. I was at the Milken conference last week and sort of the scary part of that was kind of the message was the best-case scenario is almost a frozen war, which means you’re going to have an impact on energy prices for a long period of time. Food supply is going to be another headwind. And then of course, we have China’s lock down and the zero COVID policy which is affecting supply chain. So those are your big kind of headwinds. 
    And then the tailwinds is [the] consumer’s still pretty flush, probably more flushed than they were pre-COVID. So that’s good. You’ve got the big tailwinds of the demographics in Asia, you have technological innovation. And so, to be honest, what I say to people is it’s easier to swim with the tide, the way it’s flowing. So, find areas where there’s opportunity, things like as people are doing nearshoring of supply chain, trying to figure out where there’s opportunities there. I think that the technological innovation, I think things around genomics is really impressive. I think things around precision farming, as people are trying to take more control over their food supply chain, as we see it. Now, those are not in the immediate term. It’s going to take some investment, but I think you want to get behind where the opportunities are. I think Web 3.0 is another big opportunity.

    Picker: I’m curious what you’re seeing with regard to flows right now, given all of those confounding factors affecting investing right now. Are you seeing greater interest in the active products or do you see more interest in passive where people just kind of want to ride out the tide, pay a lower fee and then kind of turn back to the market maybe in a couple years or so and see how it’s done?
    Johnson: I think flows are down across the board. I think what we’ve seen is active outperforming more. Part of that is you just look at the shift to it. I mean, the NASDAQ is down more than twice as much as the Dow, so, sort of your value growth switch…but I think across the board, people are nervous. And so, you see people holding back on the fixed income side. You see people doing bank loans, floating rate, short duration, because they know rates are going to go up and obviously that’s a really difficult time for fixed income. So, to the extent they can stay, keep flexibility. Credit really matters now. Companies that have good balance sheets, good cash flow. Again, that’s why I think you don’t see the Dow down as much because they tend to be more value stocks.
    Picker: Franklin has also been quite acquisitive, recently buying Legg Mason, a large asset manager buying other alternative asset managers, a quant fund recently. How do you think about deal making in the current environment versus building out certain capacities? And do you plan to do more acquisitions in the future?
    Johnson: We’ve been very clear about our acquisition strategy, which is to really find products that fill in particular product niches that we needed to have. Now, we are very focused on the alternatives markets. They project that about 15% or 16% of the assets in the next couple of years in the asset management business will come from alternatives, but yet 46% of revenues. So, it’s an important place for us to be and today we have $210 billion, we’re a top 10 alternatives manager. But the challenge there is, you need global products. So, if you have, for example, a real estate manager that’s just focused on the U.S., it’s hard to sell that in Europe. So, if there’s product gaps we’ll fill in. We’ve already been very clear that we want to continue to grow our wealth business, fiduciary trust. And so, as we have bolt-on acquisitions, that’ll make sense there. And then finally, Fintech is very much disrupting our business and so we make investments, sometimes just investments, sometimes acquisitions in technology products. O’Shaughnessy Asset Management has a product called Canvas, which is really tax efficient, direct indexing. We think there’s a lot of growth there. And so, we really made that acquisition for that technology platform.
    Picker: I want to home in on what you’re doing in the alternative space right now because much of Franklin Templeton’s, 75 or so year history has been in the mutual fund space, serving the retail investor. And now you have over $200 billion in alternatives, which is just broadly looking to penetrate the retail space but hasn’t quite done so on a large scale yet. Do you see that as the future? Is that something that you’re looking to do with alternatives, as you as you look to grow out that part of your business?
    Johnson:  I say that my grandfather got in the business of mutual funds because the average person couldn’t participate in the equity markets. You’re talking in the 20s. And they couldn’t participate in the equity markets, so people got this idea of pooling money and allowing them to invest. Well, today, we have half the number of public equities that we did from 2000 and there are five times the number of private equity-backed companies. So, that number has gone from about 1,700 to 8,500 and the public equities has gone from about 6,500 to 3,300. So, just from an investable universe, it’s really, really important to be able to have access to alternatives and I don’t think that trend changes. And then I – if you actually look at it, companies are waiting much longer to go public, which means much of that growth opportunity in those early years is only captured in the private markets. 
    We actually got in the venture capital business because our Franklin growth equity team was looking at deals and watching as companies waited so much longer to go public, that they can allocate up to 15% of a mutual fund in illiquid assets. So, they started to get into late-stage venture and then ultimately said, well, actually, we’re located in the heart of Silicon Valley, we should actually launch our own venture funds. So, we’re in this space, because we think – and by the way, credit is the same. You don’t see banks lending in the same way as there’s been more and more regulation around capital that is tied to their loan portfolio. So, you see this great proliferation, not only of kind of commercial and corporate loans that are done on the private credit markets, but you’re actually seeing on the direct lending consumer loans. So, you have to be able – we have to think of ourselves as finding all investment opportunities and bringing those responsibly to our clients. The fact is, alternative products have a great – they’re very illiquid, so you have to responsibly figure out how you’re going to deliver those to the alternatives channel.
    Picker: In a recent interview, you said that if you were 20, and could start fresh in any business, you would build something that leverages the blockchain ecosystem. I found this fascinating, and I just want to ask you why that is. And given that you’ve already kind of made it to the pinnacle of one of the world’s largest asset managers, how you kind of see blockchain working its way and functioning within the traditional asset management space. 
    Johnson: I like to say that Bitcoin is the greatest distraction from the greatest disruption that’s happening to financial services and other industries. Because it’s – so many of the conversations go down [is this] currency like Bitcoin, going to have a place or not? And that’s – there’s great discussion to be had there but actually, the much more interesting [question] is, what can this technology do? And if you think about what blockchain is doing is, it is creating trust. If you think about what financial services is, transactions between people are transactions that require intermediaries to prove trust, a title company that, say, you actually have ownership of this. Well, blockchain can eliminate a lot of those intermediaries, and bring buyers and sellers together, and reduce the cost of a transaction. As soon as you can reduce the cost of transaction, you can fractionalize assets at a much greater level. So, for example, you can imagine taking the Empire State Building, selling it to a million people, everybody has a token. And if I want to sell to you, Leslie, I don’t have to go to the title company. It’s all built into that smart contract. So, I think blockchain will unleash a lot of the kind of locked up illiquidity in different types of assets. 
    Secondly, I think that this kind of ownership – there are people who are using it – once you have the token, you actually can create a loyalty program. So, you already see sports teams, where they’re selling off, say, a piece of the team and really what it’s doing is it’s creating a loyalty. Imagine, you could have special coaches’ meetings, or in the NFT market, artists leveraging the token to one, validate that this piece of art is actually original and authentic, but they’re also leveraging it where only those who own the token can then have these individual meetings with artists. So, it really is an interesting way. I think it dramatically reduces some of the costs in the business, but it also unlocks this desire for kind of a social connection. More

  • in

    U.S. licenses key Covid vaccine technology to WHO so other countries can develop shots

    The NIH has licensed its stabilized spike protein technology to the WHO, President Joe Biden said.
    The technology is key component of the current Covid-19 vaccines.
    The spike protein is the component in the vaccines that induces an immune response, prompting the body to fight the virus.
    The license would help the WHO work with manufacturers around the world to produce their own Covid-19 vaccines.

    U.S. President Joe Biden delivers remarks on the authorization of the coronavirus disease (COVID-19) vaccine for kids ages 5 to 11, during a speech in the Eisenhower Executive Office Building’s South Court Auditorium at the White House in Washington, November 3, 2021.
    Evelyn Hockstein | Reuters

    President Joe Biden on Thursday said the U.S. has licensed a key technology used in the current Covid-19 vaccines to the World Health Organization, which would allow manufacturers around the world to work with the global health agency to develop their own shots against the virus.
    The National Institutes of Health has licensed its stabilized spike protein technology to the WHO and United Nations’ Medicines Patent Pool, Biden said.

    The spike protein is the component in the vaccines that induces an immune response, prompting the body to fight the virus. The NIH technology holds the proteins in a configuration that allows them to produce a more potent immune response. The WHO and the Medicines Patent Pool can now sublicense the technology to generic manufacturers around the world.
    “We are making available health technologies that are owned by the United States government, including stabilized spike protein that is used in many Covid-19 vaccines,” Biden said.
    The decision to share the vaccine technology comes ahead of a virtual global Covid-19 summit that the U.S. is co-hosting Thursday. The WHO, in a statement, said the license would make the crucial technology accessible to people in low- and middle-income countries and help end the pandemic.
    While the technology the U.S. is sharing is important, it is only one component of the vaccine and does not include the full messenger RNA code needed to make the shots. The NIH and Moderna, which worked together to develop a taxpayer-funded vaccine, are currently locked in a dispute over a separate patent for the entire mRNA. The vaccines inject the mRNA code, which directs human cells to produce harmless copies of the virus spike protein to induce an immune response.
    Negotiations between NIH and Moderna to resolve that dispute are ongoing, according to the health agency. The outcome of the dispute will have major implications for technology sharing. White House chief medical advisor Dr. Anthony Fauci, in a March call with reporters, indicated the U.S. would likely license the mRNA sequence if the dispute with Moderna is resolved in NIH’s favor.

    “Whatever it is that we can do, we will do,” Fauci said when asked about sharing the mRNA code if NIH wins the dispute. Health and Human Services Secretary Xavier Becerra, on the same call, said the U.S. would “push the envelope where the law allows us” when it comes to tech sharing.
    The WHO has repeatedly called on the vaccine makers to share their know-how, but Pfizer and Moderna have declined to license the technology behind their shots to the Medicines Patent Pool. Moderna, however, is not enforcing its patents in 92 poorer nations. Though Pfizer isn’t sharing the technology, it’s providing the U.S. government with 1 billion doses for donation to poorer nations.
    The WHO has gone around the vaccine makers, setting up a manufacturing hub in South Africa to produce vaccines based on the messenger RNA technology that Pfizer and Moderna use in their shots. South African scientists are producing generic copies of Moderna’s vaccine based on publicly available information since the biotech company isn’t enforcing its patents.
    WHO Director-General Tedros Adhanom Ghebreyesus urged Moderna shareholders at the biotech company’s annual meeting to vote in favor of a resolution that called for a third-party investigation on the feasibility of transferring technology.
    “If Moderna worked with us, we could submit the hub’s vaccine for approval at least one year sooner, which would save lives, decrease the risk of variants and reduce the pandemic’s economic toll,” Tedros said.
    The U.S. is also contributing another $200 million to the World Bank’s pandemic preparedness fund for a total contribution of $450 million, and an additional $20 million through the United States Agency for International Development to support the deployment of Covid tests and antiviral treatments in eight countries. The White House said it is also expanding its vaccine donations through Pfizer to include booster doses and shots for children.
    The donations are a far cry from the $5 billion the White House has requested from Congress to support vaccinations around the globe. Congress has failed to pass Biden’s broader request for $22.5 billion in Covid funding due to opposition from Republicans who are against spending that much.
    Senators reached a $10 billion Covid funding deal in April which did not include money for the global vaccination campaign. Republicans have blocked the Senate from passing the $10 billion in a dispute over the Centers for Disease Control and Prevention’s decision to end a controversial policy that returned asylum seekers at the nation’s border back to Mexico as a public health measure, known as Title 42.

    CNBC Health & Science

    Read CNBC’s latest global coverage of the Covid pandemic:

    WATCH LIVEWATCH IN THE APP More

  • in

    Goldman ‘deal guy’ behind Apple, GM cards leaves for fintech start-up iCreditWorks

    Scott Young, who was chief commercial officer of Goldman’s Marcus consumer business, will be joining the New Jersey-based start-up next month, according to iCreditWorks founder Stephen Sweeney.
    Young is credited with helping secure the bank’s Apple Card partnership in 2018 and oversaw a string of subsequent co-branding deals with companies including GM, JetBlue, AARP and Amazon.
    Before joining Goldman, Young helped Citigroup wrest the Costco card away from American Express in 2015.

    iCreditWorks CEO Scott Young, former chief commercial officer of Goldman Sachs Marcus.
    Courtesy: Goldman Sachs

    A Goldman Sachs executive known for securing some of the industry’s biggest credit card deals in recent years has left to join early stage start-up iCreditWorks, CNBC has learned.
    Scott Young, who was chief commercial officer of Goldman’s Marcus consumer business, will be joining the New Jersey-based company next month, according to iCreditWorks founder Stephen Sweeney.

    Young is the latest in a string of exits from Goldman’s consumer business sparked by the February 2021 defection of Omer Ismail, the former Marcus head who joined Walmart’s fintech start-up with a key deputy. Those departures include the former CFO and head of product for the business, and more recently the unit’s branding chief.
    Known informally at Goldman as the “deal guy,” Young joined in 2017 as its first head of partnerships, part of a wave of outside hires during the launch of the firm’s retail-banking division. He is credited with helping secure the bank’s Apple Card partnership in 2018 along with Ismail and former CEO Lloyd Blankfein, and oversaw a string of subsequent co-branding deals with the likes of GM, JetBlue, AARP and Amazon.
    Before joining Goldman, Young worked at GE, Barclays and then Citigroup, where he helped wrest the Costco card away from American Express in 2015. That was a seismic deal in the card industry, where the biggest contracts with companies including Costco, Amazon and American Airlines can make up a disproportionate share of an issuer’s business.
    At iCreditWorks, Young will be tasked with continuing to make deals.
    The start-up’s main product is a point of sale mobile app that handles the application, vetting and funding for personal loans. The initial target audience is health care and elective medicine, taking on industry leader CareCredit, a unit of Synchrony Bank.

    After that, they will move into other areas including auto and home-improvement loans, Sweeney said.
    “When you’re trying to build a disruptive platform that has wide commercial appeal, you need an executive who has the chops to make those deals happen,” Sweeney said. “As chief commercial officer at Goldman, he was at the nexus of all those transactions; sourcing, negotiating and securing deals.”
    Sweeney said that he and his partners, a group of serial entrepreneurs, have plowed more than $50 million into iCreditWorks since its founding three years ago. That influx of funds has helped Sweeney snap up banking veterans including Suresh Nair, who serves as chief information technology officer. Nair was a senior technology officer at Bank of America and helped engineer Merrill Lynch’s trading platform.
    The company recently hired Truist Financial to raise its first round of outside funding, seeking $50 million at a roughly $200 million valuation, Sweeney said.

    WATCH LIVEWATCH IN THE APP More

  • in

    Boeing considers redesigning problematic valve that has kept Starliner from flying NASA astronauts

    Boeing is examining whether to redesign the propulsion valves on its Starliner crew capsule.
    The key system has kept the company from flying astronauts for NASA.
    “Once we get all the information that we need, we’ll make that decision,” Boeing vice president Mark Nappi said during a news conference on Wednesday.

    Boeing’s Starliner capsule for the Orbital Flight Test 2 (OFT-2) mission is lifted on top of United Launch Alliance’s Atlas V rocket on May 4, 2022.
    Frank Michaux / NASA

    Boeing is examining whether to redesign the propulsion valves on its Starliner crew capsule, a crucial system that has kept the company from flying astronauts for NASA — and competing with Elon Musk’s SpaceX.
    Starliner is the spacecraft that Boeing has been developing under NASA’s Commercial Crew program, having won nearly $5 billion in contracts to build the capsule. But Starliner’s development has run into several obstacles. A software malfunction cut short the first uncrewed orbital flight in 2019, and a propulsion valve problem was identified before launching the second attempt last August.

    “A valve redesign is definitely on the table,” Mark Nappi, Boeing’s vice president and Commercial Crew program manager, said during a news conference Wednesday. “Once we get all the information that we need, we’ll make that decision.”
    Boeing is making another attempt at launching the Orbital Flight Test 2 (OFT-2) mission, which is set to lift off May 19 from Florida. For this attempt, the company applied a sealant to the valves. But the fix is likely a temporary solution to the issue, which in August saw 13 of the 24 oxidizer valves that control Starliner’s movement in space get stuck after launch site humidity caused corrosion.
    Depending on the outcome of OFT-2, Boeing would then prepare for a crewed flight test that would see the first astronauts fly on Starliner. A valve redesign may further delay that crewed launch, however, given the need for Boeing to test the fix and for NASA to certify the solution.
    To date, Boeing has spent $595 million as a result of the delays in working under a fixed-price contract with NASA for Starliner’s development. The space agency last year took the rare move of reassigning astronauts from Starliner to SpaceX’s Crew Dragon, which just launched the company’s seventh human spaceflight.
    Reuters first reported, citing sources, that Boeing will redesign the Aerojet Rocketdyne-made propulsion valves, although neither the plane-maker nor NASA had previously revealed the plans. Nappi confirmed that Boeing has “been looking at options for at least a month, if not more.”

    For now, Nappi said Boeing wants “to do a little more testing” to further understand how “these nitrates form inside” the valves, with those results guiding a team that’s been established.
    “We’re very confident for OFT-2 that we have a system that is going to operate properly,” Nappi said.

    WATCH LIVEWATCH IN THE APP More

  • in

    U.S. airline bookings dropped 17% in April as flights got even more expensive

    Bookings dropped last month from March, according to data from Adobe Digital Insights.
    Demand and fares are still above 2019 levels.
    Inflation has hit airline tickets especially hard as fuel and demand rose this year.

    A Southwest Airlines aircraft taxis as an American Airlines aircraft lands at Reagan National Airport in Arlington, Virginia, U.S., January 24, 2022.
    Joshua Roberts | Reuters

    U.S. airline bookings dropped 17% last month from March, according to a report from Adobe published Thursday, one of the first signs of cooling demand for air travel as ticket prices surpass pre-Covid pandemic levels.
    Consumers spent $7.8 billion on domestic tickets in April, down 13% from the previous month, according to the report.

    Air travel has been resilient in recent months despite the highest inflation since the early 1980s. Prices on everything from gasoline to groceries to travel have shot up. The new data suggests consumers are starting to back off buying tickets.
    Despite the slowdown, demand for domestic U.S. plane tickets remains above 2019 levels. In April, online spending on tickets was up 23% over the same month in 2019 while bookings rose 5%. Prices were up 27% from 2019 and 8% higher than in March, Adobe said.

    WATCH LIVEWATCH IN THE APP More

  • in

    Rivian is recalling about 500 of its electric pickups for a child-safety defect

    Rivian is recalling 502 vehicles for defective child-protection systems related to the front-seat airbag.
    The company will replace the front passenger seats in affected vehicles free of charge.

    Rivian R1T Field pickup
    Source: Rivian

    Rivian Automotive is recalling some of its electric pickups because of an airbag defect that could injure a child in a crash, according to a letter from the National Highway Traffic Safety Administration dated Wednesday.
    A total of 502 R1Ts are affected, about 10% of Rivian’s total vehicle production to date.

    New vehicles sold in the U.S. are required to have a system that deactivates the passenger-side airbag when a child or a child seat occupies the front seat. Rivian said that the system in some of its upscale R1T electric pickups may fail to work properly, putting a child in the front seat of an R1T at a greater risk of injury in a collision.
    Rivian’s service centers will replace the front passenger seats in affected vehicles free of charge. Owners of affected vehicles will receive letters by July 1, the company said. In the meantime, R1T owners can check if their vehicle is affected by entering their vehicle identification number at the NHTSA’s recall site.

    WATCH LIVEWATCH IN THE APP More

  • in

    Gasoline, diesel prices rise to another record amid rampant inflation

    Prices at the pump are at a record high.
    The national average for a gallon of gasoline hit $4.418 on Thursday, according to AAA.
    Retail diesel prices are also at an all-time high.

    A gas station is seen as the average price of gasoline reach all-time high at $4.37 per gallon (about 3.8 liters) in Virginia, USA on May 10, 2022. It’s claimed that gasoline prices vary by region.
    Yasin Ozturk | Anadolu Agency | Getty Images

    Retail diesel and gasoline prices climbed to another record high Thursday, as rampant inflation sends costs across the economy surging.
    The national average for a regular gallon of gasoline hit $4.418 on Thursday, according to AAA. The price is not adjusted for inflation.

    Prices had previously hit all-time highs on Tuesday and Wednesday.
    Consumers are now paying 32 cents per gallon more than they were last month, which translates to $125 million more per day spent on gasoline, according to GasBuddy’s Patrick De Haan.
    Prices at the pump are $1.41 more per gallon than last year.
    The national average crossed above $4 per gallon in March on the heels of Russia’s invasion of Ukraine, and it’s remained above that mark since.
    California has the highest state average at $5.853. In 10 counties across the state, average prices are now above $6.

    Retail diesel prices also hit another record Thursday. The national average for a gallon is now $5.557, which is up 53 cents in the last month.
    Part of the surge in prices is due to refiners — which turn crude oil into the products such as gasoline that are used daily — already running near full capacity.
    Refining capacity is lower than pre-pandemic, while demand for petroleum products has rebounded as economies around the world resume operations. Lost products from Russia has further exacerbated an already tight market.
    “All of our refinery margin indicators were in double-digit territory in April for the first time, regardless of region and complexity,” the International Energy Agency said Thursday. “The current almost universal product shortage, low inventories and refinery capacity bottlenecks have led to inelastic short-term supply, pushing cracks for almost all products to extraordinarily high levels.”

    WATCH LIVEWATCH IN THE APP More